Title:
抗ＡＮＧＰＴＬ８抗体を用いて肥満を処置する方法
Document Type and Number:
Japanese Patent JP7133551
Kind Code:
B2
Abstract:
The present invention provides antibodies that bind to ANGPTL8 and methods of using the same. According to certain embodiments, the invention includes methods of using anti-ANGPTL8 antibodies that bind human ANGPTL8 with high affinity to treat obesity, reduce body fat, reduce body weight, increase energy expenditure, and increase HDL-C, in a subject.
Inventors:
Victoria Gusarova
Jesper Gromada
Andrew Jay Murphy
Jesper Gromada
Andrew Jay Murphy
Application Number:
JP2019526287A
Publication Date:
September 08, 2022
Filing Date:
November 16, 2017
Export Citation:
Assignee:
REGENERON PHARMACEUTICALS, INC.
International Classes:
A61K39/395; A61P3/00; A61P3/04; A61P3/06; A61P43/00
Domestic Patent References:
| JP2018525383A | ||||
| JP2021090449A |
Other References:
PNAS, 2013, vol. 110, no. 40, pp. 1610916114
Attorney, Agent or Firm:
Junji Yuda
Noriyuki Takebayashi
Noriyuki Takebayashi